FDA label 3e64e549-6a42-cd56-e063-6394a90ab506
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- SPL set ID
- 33f276ad-a849-0fbf-e063-6394a90a9664
- SPL ID
- 3e64e549-6a42-cd56-e063-6394a90ab506
- Version
- 3
- Effective date
- 2025-09-09
- Source export date
- 2026-09-28
- Source partition
- 11
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0011-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-09-28/aa96b5a2be6b394393acd0090f6948bdf99e0e8e00666f81608929c8fa83db77/drug-label-0011-of-0014.json.zip
- Source manifest SHA-256
- cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
- Import run
- 20260929T050834Z
- Imported at
- 2026-09-29 06:16:35
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| spl id | 3e64e549-6a42-cd56-e063-6394a90ab506 | id | |
| spl set id | 33f276ad-a849-0fbf-e063-6394a90a9664 | set_id |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
WARNINGS Medicines intended to be applied to the skin should not be swallowed. Salicor™ is flammable. Keep away from open flame. You should never heat, microwave, or add the medicine to hot water.
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
adverse reactions
Serious Adverse Events (Rare but Require Immediate Medical Attention) Severe nervous system reaction: very stiff muscles, high fever, sweating, confusion, fast or uneven heartbeats, tremors, feeling like you might pass out Serious eye symptoms: blurred vision, tunnel vision, eye pain or swelling, seeing halos around lights Serious heart symptoms: fast or pounding heartbeats, fluttering in chest, shortness of breath, sudden dizziness Severe headache, confusion, slurred speech, severe weakness, loss of coordination, feeling unsteady In rare cases: blistering, peeling, redness, nausea, vomiting, or tinnitus
adverse reactions
ADVERSE REACTIONS Application Site Reactions While Salicor™ exhibits low skin irritant properties and displays low systemic absorption upon dermal administration, some patients may experience: • Localized irritation at the application site • Allergic reactions, particularly in individuals sensitive to salicylates • In rare cases: blistering, peeling, redness, nausea, vomiting, or tinnitus Serious Adverse Events (Rare but Require Immediate Medical Attention) • Serious heart symptoms: fast or pounding heartbeats, fluttering in chest, shortness of breath, sudden dizziness • Severe headache, confusion, slurred speech, severe weakness, loss of coordination, feeling unsteady • Severe nervous system reaction: very stiff muscles, high fever, sweating, confusion, fast or uneven heartbeats, tremors, feeling like you might pass out • Serious eye symptoms: blurred vision, tunnel vision, eye pain or swelling, seeing halos around lights
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.